Cardiac Surgeons Highlight the Need for Innovation Stewardship: Noteworthy in 2022.

Autor:	Netsanet A; Department of Surgery, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, CO, USA., Cotton J; Department of Surgery, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, CO, USA., Suarez-Pierre A; University of Colorado, Aurora, CO, USA., Hoffman J; Department of Surgery, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, CO, USA., Aftab M; Department of Surgery, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, CO, USA., Reece B; Department of Surgery, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, CO, USA., Rove JY; University of Colorado - Anschutz Medical Campus, Aurora, CO, USA.
Jazyk:	angličtina
Zdroj:	Seminars in cardiothoracic and vascular anesthesia [Semin Cardiothorac Vasc Anesth] 2023 Jun; Vol. 27 (2), pp. 136-144. Date of Electronic Publication: 2023 Apr 25.
DOI:	10.1177/10892532231173090
Abstrakt:	Modern cardiac surgery has rapidly evolved to treat complex cardiovascular disease. This past year boasted noteworthy advances in xenotransplantation, prosthetic cardiac valves, and endovascular thoracic aortic repair. Newer devices often offer incremental design changes while demanding significant cost increases that leave surgeons to decide if the benefit to patients justifies the increased cost. As innovations are introduced, surgeons must continuously aim to harmonize short- and long-term benefits with financial costs). We must also ensure quality patient outcomes while embracing innovations that will advance equitable cardiovascular care.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu